Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity

被引:19
作者
Urano, T
Nagai, N
Matsuura, M
Ihara, H
Takada, Y
Takada, A [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 43131, Japan
[2] Hamamatsu Univ Sch Med, Dept Pathophysiol, Hamamatsu, Shizuoka 43131, Japan
关键词
D O I
10.1055/s-0037-1615156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Employing a fibrin clot lysis assay, we reassessed the significance of the neutralization of plasminogen activator inhibitor type 1 (PAI-I) activity by thrombin and factor-Xa in fibrinolysis. When PAI-I enriched fibrin clots were formed using increasing concentrations of thrombin (0.1, 0.5, 1.0 IU/ml), their lysis times became shorter (43.8 +/- 4.9, 25.7 +/- 3.7, 13.9 +/- 0.8 h respectively). Times were shortened further by either heparin (43.9 +/- 11.0, 12.1 +/- 2.6, 3.6 +/- 0.2 h respectively) or vitronectin (17.0 +/- 1.6, 1.9 +/- 0.7, 0.9 +/- 0.0 h respectively). Factor-Xa together with Ca++ shortened the clot lysis time further. Fibrin autography revealed that both enzymes dose dependently interfered with complex formation between tPA and PAI-1, making large amounts of tPA remaining to be free form. The mechanism seems to play a role in the coagulation associated enhancement of fibrinolysis.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 38 条
[11]   THROMBIN NEUTRALIZES PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) THAT IS COMPLEXED WITH VITRONECTIN IN THE ENDOTHELIAL-CELL MATRIX [J].
EHRLICH, HJ ;
GEBBINK, RK ;
PREISSNER, KT ;
KEIJER, J ;
ESMON, NL ;
MERTENS, K ;
PANNEKOEK, H .
JOURNAL OF CELL BIOLOGY, 1991, 115 (06) :1773-1781
[12]  
EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029
[13]   TIME-RESOLVED POLARIZED FLUORESCENCE SPECTROSCOPY STUDIES OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - CONFORMATIONAL-CHANGES OF THE REACTIVE CENTER UPON INTERACTIONS WITH TARGET PROTEASES, VITRONECTIN AND HEPARIN [J].
FA, M ;
KAROLIN, J ;
ALESHKOV, S ;
STRANDBERG, L ;
JOHANSSON, LBA ;
NY, T .
BIOCHEMISTRY, 1995, 34 (42) :13833-13840
[14]  
GABRIEL DA, 1992, J BIOL CHEM, V267, P24259
[15]   SPECIFIC GLYCOSAMINOGLYCANS SUPPORT THE INHIBITION OF THROMBIN BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
GEBBINK, RK ;
REYNOLDS, CH ;
TOLLEFSEN, DM ;
MERTENS, K ;
PANNEKOEK, H .
BIOCHEMISTRY, 1993, 32 (06) :1675-1680
[16]   STUDY OF PROTEASES AND PROTEASE-INHIBITOR COMPLEXES IN BIOLOGICAL-FLUIDS [J].
GRANELLIPIPERNO, A ;
REICH, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (01) :223-234
[17]  
HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912
[18]   IMPLICATIONS OF THE 3-DIMENSIONAL STRUCTURE OF ALPHA-1-ANTITRYPSIN FOR STRUCTURE AND FUNCTION OF SERPINS [J].
HUBER, R ;
CARRELL, RW .
BIOCHEMISTRY, 1989, 28 (23) :8951-8966
[19]  
JACKSON CM, 1984, PROG HEMOST THROMB, V7, P55
[20]   DETERMINATION OF OPERATIONAL MOLARITY OF SOLUTIONS OF BOVINE ALPHA-CHYMOTRYPSIN, TRYPSIN, THROMBIN AND FACTOR XA BY SPECTROFLUORIMETRIC TITRATION [J].
JAMESON, GW ;
ROBERTS, DV ;
ADAMS, RW ;
KYLE, WSA ;
ELMORE, DT .
BIOCHEMICAL JOURNAL, 1973, 131 (01) :107-117